J. Forbes

发表

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes

D. Arnold, A. Bar-Or, Yinshan Zhao, 2021, Annals of clinical and translational neurology.

Metagenomics: The Next Culture-Independent Game Changer

J. Ronholm, F. Pagotto, N. Knox, 2017, Front. Microbiol..

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?

R. Marrie, G. Van Domselaar, C. Bernstein, 2018, Microbiome.

Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases

A. Bar-Or, Yinshan Zhao, B. Banwell, 2022, Multiple sclerosis.

Clinically Important Toxins in Bacterial Infection: Utility of Laboratory Detection

J. Forbes, 2020, Clinical Microbiology Newsletter.

Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern

Samir N. Patel, V. Allen, T. Mazzulli, 2022, Microbiology spectrum.

Real-time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with Variants of Concern

V. Allen, T. Mazzulli, N. Fittipaldi, 2021, medRxiv.

The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome.

D. Arnold, A. Bar-Or, Yinshan Zhao, 2022, Multiple sclerosis and related disorders.

Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.

M. Drebot, L. R. Lindsay, J. Forbes, 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Highlighting Clinical Metagenomics for Enhanced Diagnostic Decision-making: A Step Towards Wider Implementation

Natalie C. Knox, Jessica D. Forbes, Christy-Lynn Peterson, 2018, Computational and Structural Biotechnology Journal.

The Gut Microbiota in Immune-Mediated Inflammatory Diseases

G. Van Domselaar, C. Bernstein, J. Forbes, 2016, Front. Microbiol..

A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.

L. Lix, G. Van Domselaar, M. Graham, 2017, Clinical nutrition.

The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?

G. Domselaar, C. Bernstein, N. Knox, 2019, Current Treatment Options in Gastroenterology.

Association of Exposure to Formula in the Hospital and Subsequent Infant Feeding Practices With Gut Microbiota and Risk of Overweight in the First Year of Life

H. Tun, M. Sears, D. Guttman, 2018, JAMA pediatrics.

The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.

G. Van Domselaar, C. Bernstein, N. Knox, 2019, The American journal of gastroenterology.

Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome

D. Arnold, A. Bar-Or, Yinshan Zhao, 2021, Neurology.

Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.

Samir N. Patel, J. Forbes, J. Kus, 2021, Anaerobe.

Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data

G. Van Domselaar, C. Bernstein, N. Knox, 2021, Frontiers in Cell and Developmental Biology.

The multiple sclerosis gut microbiota: A systematic review.

E. Waubant, G. Van Domselaar, M. Graham, 2020, Multiple sclerosis and related disorders.

Assessment of Inter-Laboratory Variation in the Characterization and Analysis of the Mucosal Microbiota in Crohn’s Disease and Ulcerative Colitis

M. Surette, G. Van Domselaar, M. Graham, 2020, Frontiers in Microbiology.

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?

R. Marrie, G. Van Domselaar, C. Bernstein, 2018, Microbiome.

Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results

Samir N. Patel, V. Allen, T. Mazzulli, 2021, Infection control and hospital epidemiology.

Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results

V. Allen, T. Mazzulli, N. Fittipaldi, 2021, medRxiv.

Yeast: An overview

J. Forbes, A. Speers, 2015 .

Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases

C. Bernstein, J. Forbes, 2017, Inflammatory Intestinal Diseases.

Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients

G. Van Domselaar, C. Bernstein, J. Forbes, 2016, Inflammatory bowel diseases.

Clinical Metagenomics Is Increasingly Accurate and Affordable to Detect Enteric Bacterial Pathogens in Stool

Eduardo N. Taboada, M. Graham, N. Knox, 2022, Microorganisms.

A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease?

G. Van Domselaar, C. Bernstein, H. Tremlett, 2019, Front. Microbiol..

Wound swab quality grading is dependent on Gram smear screening approach

S. Clark, L. Matukas, J. Forbes, 2023, Scientific Reports.

Use of a taxon-specific reference database for accurate metagenomics-based pathogen detection of Listeria monocytogenes in turkey deli meat and spinach

C. Nadon, G. Van Domselaar, M. Graham, 2023, BMC Genomics.

Microbiome profiling of drinking water in relation to incidence of inflammatory bowel disease.

G. Van Domselaar, C. Bernstein, J. Forbes, 2016, Canadian journal of microbiology.

Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage

J. Forbes, M. Smieja, S. Chong, 2020, Journal of Clinical Microbiology.

Breast milk , formula , the microbiome and overweight

M. Azad, J. Forbes, 2018 .

Verification of a Support Vector Machine Model for Predicting Proteotypic Peptides

Jessica Forbes, J. Forbes, 2010 .